CS208724B2 - Method of making the 5-(2-furoyl)-,5-(2-thonoyl)-,5-(3-furoyl) a 5-(3-thenoyl)-1,2-dihydro-3h-pyrrol/1,2-a/pyrrol-1-karboxyl acid derivatives - Google Patents
Method of making the 5-(2-furoyl)-,5-(2-thonoyl)-,5-(3-furoyl) a 5-(3-thenoyl)-1,2-dihydro-3h-pyrrol/1,2-a/pyrrol-1-karboxyl acid derivatives Download PDFInfo
- Publication number
- CS208724B2 CS208724B2 CS774647A CS464777A CS208724B2 CS 208724 B2 CS208724 B2 CS 208724B2 CS 774647 A CS774647 A CS 774647A CS 464777 A CS464777 A CS 464777A CS 208724 B2 CS208724 B2 CS 208724B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- pyrrole
- formula
- dihydro
- carboxylic acid
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70485776A | 1976-07-14 | 1976-07-14 | |
| US05/771,283 US4087539A (en) | 1976-07-14 | 1977-02-23 | 5-(2-Furoyl)-, 5-(2-thenoyl)-, 5-(3-furoyl)- and 5-(3-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS208724B2 true CS208724B2 (en) | 1981-09-15 |
Family
ID=27107392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS774647A CS208724B2 (en) | 1976-07-14 | 1977-07-12 | Method of making the 5-(2-furoyl)-,5-(2-thonoyl)-,5-(3-furoyl) a 5-(3-thenoyl)-1,2-dihydro-3h-pyrrol/1,2-a/pyrrol-1-karboxyl acid derivatives |
Country Status (26)
| Country | Link |
|---|---|
| JP (1) | JPS539789A (el) |
| AR (1) | AR218631A1 (el) |
| AU (1) | AU513385B2 (el) |
| CA (1) | CA1100140A (el) |
| CH (2) | CH651045A5 (el) |
| CS (1) | CS208724B2 (el) |
| DE (1) | DE2731662A1 (el) |
| DK (1) | DK152652C (el) |
| ES (2) | ES460705A1 (el) |
| FI (1) | FI63407C (el) |
| FR (1) | FR2361396A1 (el) |
| GB (1) | GB1554076A (el) |
| GR (1) | GR61607B (el) |
| HK (1) | HK17581A (el) |
| IE (1) | IE45302B1 (el) |
| IL (1) | IL52492A (el) |
| IT (1) | IT1117314B (el) |
| MY (1) | MY8100371A (el) |
| NL (1) | NL7707652A (el) |
| NO (1) | NO147563C (el) |
| NZ (1) | NZ184611A (el) |
| PL (1) | PL111408B1 (el) |
| PT (1) | PT66779B (el) |
| SE (1) | SE434644B (el) |
| SU (2) | SU664566A3 (el) |
| YU (2) | YU43157B (el) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4097579A (en) * | 1977-03-31 | 1978-06-27 | Syntex (U.S.A.) Inc. | 5-(2-Pyrroyl)-1,2-dihydro-3H-pyrrolo 1,2-a!pyrrole-1-carboxylic acid derivatives and process for the production thereof |
| US4140698A (en) * | 1977-07-25 | 1979-02-20 | Syntex (Usa) Inc. | 1,2-Dihydro-3H-pyrrolo[1,2-a]pyrrole-1-nitriles |
| US4353829A (en) * | 1980-11-21 | 1982-10-12 | Syntex (U.S.A.) Inc. | Process for 5-aroylation of 1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic esters |
| US4511724A (en) * | 1982-06-10 | 1985-04-16 | Merck & Co., Inc. | 5-(Pyrrol-2-oyl)-1,2-dihydro-3H-pyrrolo [1,2-a]pyrrole derivatives as anti-inflammatory and analgesic agents |
| JPS5910589A (ja) * | 1982-06-10 | 1984-01-20 | メルク エンド カムパニー インコーポレーテツド | 抗炎症剤および鎮痛剤として新規な５−（ピロ−ル−２−オイル）−１，２−ジヒドロ−３Ｈ−ピロロ〔１，２−ａ〕ピロ−ル誘導体 |
| HU198927B (en) * | 1987-01-14 | 1989-12-28 | Richter Gedeon Vegyeszet | Process for producing 1-/substituted aminomethyl/-octa-hydroindolo-(2,3-a)quinolizine derivatives, pharmaceutically applicable acid addition salts thereof, as well as pharmaceutical compositions comprising same |
| US4874871A (en) * | 1987-03-25 | 1989-10-17 | Syntex (U.S.A.) Inc. | Process for preparing (+)-2,3-Dihydro-1H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid and related compounds |
-
1977
- 1977-05-17 JP JP5697877A patent/JPS539789A/ja active Granted
- 1977-07-07 GR GR53906A patent/GR61607B/el unknown
- 1977-07-07 AR AR268357A patent/AR218631A1/es active
- 1977-07-07 DK DK307677A patent/DK152652C/da not_active IP Right Cessation
- 1977-07-08 CH CH4005/84A patent/CH651045A5/de not_active IP Right Cessation
- 1977-07-08 IL IL52492A patent/IL52492A/xx unknown
- 1977-07-08 IE IE1422/77A patent/IE45302B1/en unknown
- 1977-07-08 CH CH848877A patent/CH644861A5/de not_active IP Right Cessation
- 1977-07-08 NL NL7707652A patent/NL7707652A/xx not_active Application Discontinuation
- 1977-07-08 PT PT66779A patent/PT66779B/pt unknown
- 1977-07-11 FI FI772154A patent/FI63407C/fi not_active IP Right Cessation
- 1977-07-11 NZ NZ184611A patent/NZ184611A/xx unknown
- 1977-07-11 GB GB28923/77A patent/GB1554076A/en not_active Expired
- 1977-07-12 CA CA282,600A patent/CA1100140A/en not_active Expired
- 1977-07-12 CS CS774647A patent/CS208724B2/cs unknown
- 1977-07-12 FR FR7721559A patent/FR2361396A1/fr active Granted
- 1977-07-13 IT IT68631/77A patent/IT1117314B/it active
- 1977-07-13 SE SE7708142A patent/SE434644B/xx not_active IP Right Cessation
- 1977-07-13 PL PL1977199602A patent/PL111408B1/pl unknown
- 1977-07-13 NO NO772493A patent/NO147563C/no unknown
- 1977-07-13 AU AU26976/77A patent/AU513385B2/en not_active Expired
- 1977-07-13 SU SU772504151A patent/SU664566A3/ru active
- 1977-07-13 DE DE19772731662 patent/DE2731662A1/de active Granted
- 1977-07-13 ES ES460705A patent/ES460705A1/es not_active Expired
- 1977-12-29 SU SU772558960A patent/SU793400A3/ru active
-
1978
- 1978-05-24 ES ES470213A patent/ES470213A1/es not_active Expired
-
1981
- 1981-04-30 HK HK175/81A patent/HK17581A/xx unknown
- 1981-12-30 MY MY371/81A patent/MY8100371A/xx unknown
-
1983
- 1983-02-28 YU YU476/83A patent/YU43157B/xx unknown
- 1983-02-28 YU YU475/83A patent/YU43156B/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022523786A (ja) | ピラジン誘導体およびｓｈｐ２の阻害の際のその適用 | |
| US4087539A (en) | 5-(2-Furoyl)-, 5-(2-thenoyl)-, 5-(3-furoyl)- and 5-(3-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof | |
| KR100494347B1 (ko) | 2-아릴-8-옥소디히드로푸린 유도체, 그의 제조방법, 이를함유하는 의약조성물, 및 이 화합물의 중간체 | |
| US4097579A (en) | 5-(2-Pyrroyl)-1,2-dihydro-3H-pyrrolo 1,2-a!pyrrole-1-carboxylic acid derivatives and process for the production thereof | |
| US7820680B2 (en) | HIV integrase inhibitors | |
| JPS6254792B2 (el) | ||
| US4000275A (en) | Immunosuppressants | |
| DE10034623A1 (de) | Heterocyclisch substituierte Pyridine als Cytokin-Inhibitoren | |
| TW201443033A (zh) | 可作為鈉依賴性葡萄糖轉運子（ｓｇｌｔ）抑制劑之化合物之製備方法 | |
| JP2002542245A (ja) | 置換イミダゾール、それらの製造および使用 | |
| JP2003533453A (ja) | ホスホジエステラーゼ阻害剤として有効なβ−カルボリン誘導体 | |
| GB2244487A (en) | Azple derivatives | |
| WO2019154395A1 (zh) | 四氢异喹啉类化合物、其制备方法、包含此类化合物的药物组合物及其用途 | |
| WO2004113345A1 (ja) | 縮合ピロール化合物及びその医薬用途 | |
| JP4717210B2 (ja) | 男性の勃起機能障害の処置のための５−ヘテロシクリルピラゾロ［４，３−ｄ］ピリミジン−７−オン | |
| CS208724B2 (en) | Method of making the 5-(2-furoyl)-,5-(2-thonoyl)-,5-(3-furoyl) a 5-(3-thenoyl)-1,2-dihydro-3h-pyrrol/1,2-a/pyrrol-1-karboxyl acid derivatives | |
| CS204954B2 (en) | Method of producing derivatives of 5-aroyl-1,2-dihydro-3h-pyrrole/2,2-a/pyrrole-1-carboxylic acid | |
| NL193541C (nl) | 8 Alfa-acylaminoergolinen, werkwijzen voor de bereiding daarvan en preparaten die ze bevatten. | |
| JP2750869B2 (ja) | 三環式縮合ピリミジン誘導体 | |
| DE69907923T2 (de) | Triazolopyridazinderivate zur verbesserung der kognitiven funktionen | |
| TW200407148A (en) | Novel interleukin-1β converting enzyme inhibitors | |
| US4560699A (en) | 5-(4-Vinylbenzoyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]-pyrrole-1-carboxylic acids and derivatives thereof and use as analgesics and anti-inflammatories | |
| JPH02289518A (ja) | アデノシン拮抗剤 | |
| JPS6157583A (ja) | ピラゾロ‐〔３，４‐ｂ〕‐ピリジンラクタム、該ラクタムの製造方法及び該ラクタムを含有する不安解消性製剤組成物 | |
| DK152501B (da) | Fremgangsmaade til fremstilling af pyrrolooe1,2-aaapyrimidiner eller salte deraf |